Atossa Therapeutics
ATOS
ATOS
23 hedge funds and large institutions have $1.79M invested in Atossa Therapeutics in 2020 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
33% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 3
0.25% more ownership
Funds ownership: 0.23% → 0.47% (+0.25%)
Holders
23
Holding in Top 10
–
Calls
$63K
Puts
$33K
Top Buyers
| 1 | +$421K | |
| 2 | +$282K | |
| 3 | +$238K | |
| 4 |
Two Sigma Investments
New York
|
+$134K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$78.5K |
Top Sellers
| 1 | -$65K | |
| 2 | -$1.49K | |
| 3 | -$624 | |
| 4 |
CG
Cutler Group
San Francisco,
California
|
-$336 |